| Date Filed | Type | Description |
| 02/14/2014 |
SC 13G/A
| KPCB PANDEMIC & BIO DEFENSE FUND LLC reports a 0% stake in Trius Therapeutics, Inc. |
| 09/13/2013 |
SC 13D/A
| CUBIST PHARMACEUTICALS INC has filed a Schedule 13D for Trius Therapeutics Inc |
| 09/11/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/11/2013 |
8-K
| Quarterly results |
| 09/11/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/11/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 09/05/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/03/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/29/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/26/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 08/14/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/13/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 08/13/2013 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 08/09/2013 |
SC 13D
| Trius Therapeutics Inc reports a 27.5% stake in TRIUS THERAPEUTICS, INC. |
| 08/07/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 08/06/2013 |
8-K
| Quarterly results |
| 08/02/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 08/01/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 08/01/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 07/30/2013 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 07/25/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 05/08/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 05/07/2013 |
8-K
| Quarterly results |
| 04/15/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/25/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/13/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/13/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 03/13/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/12/2013 |
8-K
| Quarterly results |
| 02/11/2013 |
SC 13G/A
| Versant Side Fund III, L.P. reports a 8.3% stake in Trius Therapeutics, Inc. |
| 01/18/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 01/18/2013 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 01/18/2013 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 01/07/2013 |
8-K
| Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits |
|